Cancer Drug Approvals That Displaced Existing Standard-of-Care Therapies, 2016-2021

IMPORTANCE: Although several cancer drugs receive US Food and Drug Administration (FDA) approval each month, it is unclear how many of these cancer drugs transform the treatment landscape significantly by tumor group. Specifically, it remains unclear how many of these newly approved cancer drugs dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Benjamin, David J., Xu, Alexander, Lythgoe, Mark P., Prasad, Vinay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8924721/
https://www.ncbi.nlm.nih.gov/pubmed/35289858
http://dx.doi.org/10.1001/jamanetworkopen.2022.2265

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8924721/
https://www.ncbi.nlm.nih.gov/pubmed/35289858
http://dx.doi.org/10.1001/jamanetworkopen.2022.2265

Ejemplares similares